The sodium-glucose transporter (SGLT2) drugs for diabetes have some senolytic properties (getting rid of senescent cells) and better than expected health outcomes. They are candidate drugs for extending healthspan (as also reviewed in SUPER AGERS)
by @AlexLJanin

→ View original post on X — @erictopol